AI Article Synopsis
- Ovarian cancer frequently spreads within the peritoneal cavity, known as peritoneal carcinomatosis.
- This localized spread allows for targeted delivery of immunotherapy treatments directly to the affected area, which can increase the effectiveness of the drugs.
- This approach may minimize the side effects typically associated with systemic treatment methods.
Article Abstract
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects. See related article by Orr et al., p. 2038.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/1078-0432.CCR-22-0201 | DOI Listing |
Publication Analysis
Top Keywords
revisiting intracavitary
4
intracavitary immunotherapy
4
immunotherapy cancer
4
cancer ovarian
4
ovarian cancer
4
cancer limited
4
limited peritoneal
4
peritoneal cavity
4
cavity form
4
form peritoneal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!